BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7788066)

  • 1. Current therapies in motor neurone disease.
    Goonetilleke A
    Br J Hosp Med; 1995 Apr 5-18; 53(7):314-7. PubMed ID: 7788066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2003; (4):CD003457. PubMed ID: 14583978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003457. PubMed ID: 18425887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease.
    Jackson CE; Rosenfeld J
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):335-52, ix-x. PubMed ID: 11345011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multifocal motor neuropathy. Immediate response to intravenous immunoglobulin].
    Cammarota A; Nogués M; Rivero A; García H
    Medicina (B Aires); 2001; 61(4):441-4. PubMed ID: 11563174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease associated with copper deficiency.
    Weihl CC; Lopate G
    Muscle Nerve; 2006 Dec; 34(6):789-93. PubMed ID: 16929546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor neuron disease associated with multiple myeloma.
    Koc F; Paydas S; Yerdelen D; Demirkiran M
    Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron diseases and neurotoxic substances: a possible link?
    Chang PA; Wu YJ
    Chem Biol Interact; 2009 Jul; 180(2):127-30. PubMed ID: 19497409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models for motor neuron disease.
    Green SL; Tolwani RJ
    Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis. Potential and pitfalls.
    Henderson CE
    Adv Neurol; 1995; 68():235-40. PubMed ID: 8787235
    [No Abstract]   [Full Text] [Related]  

  • 16. Will ciliary neurotrophic factor slow progression of motor neuron disease?
    Longo FM
    Ann Neurol; 1994 Aug; 36(2):125-7. PubMed ID: 8053646
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic factors in the treatment of motor neuron disease and trauma.
    DiStefano PS
    Exp Neurol; 1993 Nov; 124(1):56-9. PubMed ID: 8282081
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of growth factors in the treatment of motor neuron diseases.
    Windebank AJ
    Adv Neurol; 1995; 68():229-34. PubMed ID: 8787234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenotypes in ALS--clinical features and pathology].
    Sasaki S
    Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.